Daratumumab-Based Combo Boosts Multiple Myeloma Survival

(MedPage Today) -- Adding daratumumab (Darzalex) to lenalidomide (Revlimid) and dexamethasone--the DRd regimen--boosted survival in newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplant, an updated analysis...